Trial site
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine
- 13running trials
- 6closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Pancreatic cancer5 trials
- Acute myeloid leukaemia2 trials
- Hepatitis B2 trials
- Alopecia areata1 trial
- Alzheimer disease1 trial
- Chronic kidney disease1 trial
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- Macular degeneration1 trial
- Mild cognitive impairment1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- and 2 more
- Phase
- Phase 25 trials
- Phase 35 trials
- Phase 12 trials
- Phase 1/22 trials
- Early phase 11 trial
- Status
- Recruiting8 trials
- Completed5 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Ruijin Hospital6 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.4 trials
- CARsgen Therapeutics Co., Ltd.2 trials
- Pfizer2 trials
- Amgen1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
Recruiting
Recruiting
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
Recruiting
Recruiting
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Recruiting
Recruiting
Not yet recruiting
Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
Active, not recruiting
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Pancreatic cancer4 recruiting
- Acute myeloid leukaemia2 recruiting
- Alzheimer disease1 recruiting
- High blood pressure1 recruiting
- Macular degeneration1 recruiting
- Mild cognitive impairment1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026